Fresenius Group is a global healthcare company headquartered in Bad Homburg vor der Höhe, Germany, with a history spanning more than 100 years. The company provides system-critical products and services across leading therapies for the care of critically and chronically ill patients. It employs around 176,000 people (excluding Fresenius Medical Care) and reported annual revenue of €21.5 billion in fiscal year 2024.
The group operates through several major business segments. Fresenius Kabi supplies products for critically and chronically ill patients, including clinical nutrition and pharmaceuticals. Fresenius Helios is Europe's leading private hospital operator. Fresenius Medical Care is the world's leading provider of dialysis products and services, serving approximately 4.5 million patients worldwide.
Fresenius maintains a presence across Europe, the Americas, and other global markets. Under its #FutureFresenius program, the company focuses on three therapy platforms: (Bio)Pharma including clinical nutrition, MedTech, and Care Provision. Its stated mission is to save and improve human lives with affordable, accessible, and innovative healthcare products and the highest quality in clinical care.
